DRUG · Unmapped registry intervention
DUPIXENT®
Find medicine records ·
Find other trials using this name
Clinical trial
Registry of Asthma Patients Initiating DUPIXENT®
NCT04287621
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedRegistry of Asthma Patients Initiating DUPIXENT®
Design: OBSERVATIONAL · Status: COMPLETED · Phase: Not specified
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
DUPIXENT®DRUG
Sponsors & collaborators
Regeneron Pharmaceuticalslead sponsor
Sanoficollaborator
Mapped research locations
San JuanPuerto Rico3BarcelonaCatalonia, Spain3ChicagoIllinois, United States2St LouisMissouri, United States2TorontoOntario, Canada2San AntonioTexas, United States2LondonUnited Kingdom2Oklahoma CityOklahoma, United States2Ann ArborMichigan, United States2VancouverBritish Columbia, Canada2HollywoodFlorida, United States2Overland ParkKansas, United States2
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04287621 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.